Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.055 | 0.7 |